Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
54.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
7.2% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
24.6% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Outset Medical
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
US Dialysis Pricing Pressure Will Hamper Prospects Despite Emerging Positivity
Key Takeaways Heavy reliance on a single flagship device risks revenue and margin stability if competition, regulatory issues, or market shifts occur. Growth opportunities from healthcare consumerization and recurring revenue face challenges from tighter reimbursement, capital intensity, and evolving at-home treatment models.
View narrative
US$17.00
FV
19.3% undervalued
intrinsic discount
9.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
9 days ago
author updated this narrative
Energy Vault Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Global Energy Storage Will Confront Challenges And Create Opportunities
Key Takeaways Aggressive growth expectations and optimism about recurring cash flows may not materialize due to project execution risks and potential regulatory or market headwinds. Dependence on favorable policies and competition from alternative storage technologies threaten long-term market position and could pressure margins and valuation.
View narrative
US$1.10
FV
45.5% overvalued
intrinsic discount
117.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
12 days ago
author updated this narrative
Beachbody Company
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Digital Fitness Pressures And Regulatory Costs Will Erode Value
Key Takeaways Persistent subscriber churn and heightened competition from tech giants are expected to reduce revenue growth and erode Beachbody's pricing power and earnings prospects. Rising regulatory compliance costs and commoditization in digital fitness threaten Beachbody's profitability, subscriber retention, and differentiation in an oversaturated market.
View narrative
US$4.00
FV
42.3% overvalued
intrinsic discount
-26.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
CareCloud
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Rising Costs In Healthcare IT And Consolidation Will Squeeze Margins
Key Takeaways Mounting regulatory and customer pressures are likely to drive up costs, limit pricing power, and squeeze profitability amid industry consolidation. Reliance on acquisitions and lagging end-to-end solution offerings threaten stability, increase integration risk, and could erode long-term relevance and revenue retention.
View narrative
US$2.25
FV
41.3% overvalued
intrinsic discount
3.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Modulight Oyj
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Delayed Approvals Will Hamper Precision Medicine Despite Future Promise
Key Takeaways Heavy reliance on a few products and customers, alongside regulatory and reimbursement delays, causes unpredictable revenue and margin pressures despite promising market trends. Persistent prototype, validation, and scaling hurdles may slow commercialization, making sustainable earnings and positive cash flow challenging amid high expansion and compliance costs.
View narrative
€1.50
FV
8.0% undervalued
intrinsic discount
29.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
BHIA
Grupo Casas Bahia
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Legacy Stores Will Cripple Margins While Digital Shifts Provide Relief
Key Takeaways Increasing digital competition and consumer shift to online shopping threaten profitability, despite operational improvements and financial service expansion. Persistent macroeconomic challenges and rising costs may constrain margin growth and earnings momentum, even with gains in logistics and formal retail share.
View narrative
R$3.00
FV
4.0% overvalued
intrinsic discount
4.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
Lucid Diagnostics
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Medicare Coverage Delays Will Exacerbate Cash Burn Yet Yield Recovery
Key Takeaways Lucid faces significant risks from slow clinician adoption, uncertain reimbursement, and evolving regulatory landscapes, potentially delaying revenue growth and path to profitability. Ongoing high cash burn and potential for increased dilution or debt could constrain long-term financial stability, despite a favorable market outlook for early cancer detection.
View narrative
US$2.00
FV
42.0% undervalued
intrinsic discount
62.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
ANGLE
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Regulatory Scrutiny And Binary Deals Will Hinder Precision Medicine
Key Takeaways Regulatory hurdles and deal timing uncertainty create risks for revenue growth and may lead to irregular or delayed earnings progression despite industry momentum. Heavy reliance on core technology and tight research funding environment expose the company to innovation risk and constrain diversification and profitability improvements.
View narrative
UK£0.17
FV
61.8% undervalued
intrinsic discount
51.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
BlackSky Technology
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Gen-3 Satellite And Spectra Analytics Will Expand International Markets
Key Takeaways Expansion of satellite and analytics capabilities is driving strong demand, international growth, and premium pricing while reducing reliance on U.S. government contracts. Investments in new technologies and market segments position BlackSky to capitalize on rising global demand for real-time geospatial intelligence and diversify future revenues.
View narrative
US$24.38
FV
28.1% undervalued
intrinsic discount
30.09%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Value any company in seconds
Popular companies